GeneType Clinicians’ Adoption Growing – Sales up 5-Fold Year on Year
MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader...
Diagnostics
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 15, 2024 /PRNewswire/ -- The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms,...
Q4HE Initiative Recognized for Efforts To Reduce Health Disparities
NORTHAMPTON, MA / ACCESSWIRE / April 15, 2024 / Quest for Health Equity (Q4HE) was recently honored by the Y...
Nexstim Plc Resolved on a New Stock Option Plan 2024H
Company Announcement, Helsinki, 12 April 2024 at 9 PM (EEST) Nexstim Plc Resolved on a New Stock Option Plan 2024H...
Oncocyte Reports Full Year 2023 Financial Results
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ETIRVINE, Calif., April 12, 2024 (GLOBE...
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company,...
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring...
PMD Device Solutions Signs Transfer Agreement for Key Assets in Coala-Life Group AB to Accelerate its US Market Entry
STOCKHOLM, SWEDEN / ACCESSWIRE / April 11, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) ("PMDS") today announced it has signed a...
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in...
Digostics and AgaMatrix Partner to Introduce Oral Glucose Tolerance Home Testing for UK Expectant Mothers
Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance...
My Quest Story – Jessica Clow
NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / Quest Diagnostics:I began working at Quest Diagnostics in December 2020. Having...
Gemina Labs Announces Addition to its IP Portfolio
VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") today announces that it...
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in...
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before...
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary hypertension...
Mainz Biomed Reports Full Year 2023 Financial Results
ColoAlert® Revenue Increased 69% Year Over Year; Net Loss in Line with Previous Year; Cash Balance at Year End of...
Jaya Biosciences Presents New Paradigm for the Treatment of Alzheimer’s Disease at the 23ʳᵈ Annual Needham Virtual Healthcare Conference
- Data presented highlight the potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s -SOUTH SAN FRANCISCO,...
PMD Device Solutions Intends to Acquire Key Assets in Coala-Life Group AB to Accelerate its US Market Entry
STOCKHOLM, SWEDEN / ACCESSWIRE / April 9, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions ("PMDS") today announced it...
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated...